|
EIF4A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.59650000009349E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9792000000306E-07 |
| Normal-vs-Stage2 |
5.372200E-02 |
| Normal-vs-Stage3 |
4.758100E-04 |
| Normal-vs-Stage4 |
2.322200E-01 |
| Stage1-vs-Stage2 |
2.712800E-01 |
| Stage1-vs-Stage3 |
7.567000E-01 |
| Stage1-vs-Stage4 |
1.690360E-01 |
| Stage2-vs-Stage3 |
4.186000E-01 |
| Stage2-vs-Stage4 |
6.022600E-01 |
| Stage3-vs-Stage4 |
1.990240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.71560000048221E-07 |
| Normal-vs-AfricanAmerican |
1.398690E-03 |
| Normal-vs-Asian |
1.077620E-01 |
| Caucasian-vs-AfricanAmerican |
4.014200E-01 |
| Caucasian-vs-Asian |
6.197400E-01 |
| AfricanAmerican-vs-Asian |
8.558600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.49669999621938E-08 |
| Normal-vs-Female |
2.462000E-02 |
| Male-vs-Female |
2.164000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.880800E-03 |
| Normal-vs-Extreme_Weight |
1.17089999995823E-06 |
| Normal-vs-Obese |
7.402300E-04 |
| Normal-vs-Extreme_Obese |
5.108200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.265200E-01 |
| Normal_Weight-vs-Obese |
8.946600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.934600E-01 |
| Extreme_Weight-vs-Obese |
2.834400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.646400E-01 |
| Obese-vs-Extreme_Obese |
7.113000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.458030E-01 |
| Normal-vs-Age(41-60Yrs) |
2.403600E-04 |
| Normal-vs-Age(61-80Yrs) |
8.43830000318846E-08 |
| Normal-vs-Age(81-100Yrs) |
1.65979999999788E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.903000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.428190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.890400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.973800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.778300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.697200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.22409999703655E-08 |
| Normal-VS-Type2 PRCC |
2.21440000003348E-06 |
| Normal-VS-KIRP CIMP |
8.383400E-01 |
| Normal-VS-Unclassified PRCC |
1.656380E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.399000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.776100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.714800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.483800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.174800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.009800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.65799999974593E-07 |
| Normal-vs-N1 |
1.642550E-01 |
| Normal-vs-N2 |
5.390200E-02 |
| N0-vs-N1 |
1.796070E-02 |
| N0-vs-N2 |
6.614000E-01 |
| N1-vs-N2 |
4.887000E-01 |
|
|
